<DOC>
	<DOCNO>NCT01909115</DOCNO>
	<brief_summary>Vitamin D deficiency common general population common child chronic kidney disease . Vitamin D important bone health , especially child chronic kidney disease . To date , several study use different dos vitamin D try correct vitamin D deficiency , none completely successful . The investigator compare two different dos vitamin D determine one effective correct maintain normal blood level vitamin D. The investigator hypothesize high percentage child receive high dose vitamin D vitamin D replete end 6 month . This study enroll 80 child 9 18 year old chronic kidney disease take pill . They enrol Chronic Renal Insufficiency Clinic , Hemodialysis Unit , Peritoneal Dialysis Clinic Transplant Clinic Children 's Healthcare Atlanta . After investigator obtain informed consent assent , child randomly assign either low dose ( 1000 unit daily ) high dose ( 4000 unit daily ) vitamin D pill ( 50 % group ) . Patients study 6 month . They take vitamin D pills 6 month . Vitamin D level obtain baseline , 3 month 6 month . The study visit time routine clinic visit child blood drawn routine care . At end study , investigator compare percentage patient normal vitamin D level 6 month two group . The investigator also describe percentage patient elevate low level trace element . The two dos vitamin D study within dose range recommend Institute Medicine , thus investigator anticipate adverse effect . Vitamin D toxicity could theoretically occur , elevate vitamin D level 3 month would indication withdraw patient study .</brief_summary>
	<brief_title>Randomized Study Two Vitamin D Dosing Strategies Children With Chronic Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>1 . Patient 's parent/legal guardian must willing able give write informed consent patient must willing give write informed assent applicable . 2 . Estimated glomerular filtration rate &lt; 60 mL/min/1.73 m2 body surface area recipient kidney transplant 3 . 919 year old 4 . Able swallow pill 1 . Liver failure 2 . Malabsorption 3 . Current calcium level &gt; 10.5 mg/dL 4 . History hypercalcemia ( Ca &gt; 11 mg/dL ) precede 6 month 5 . Current treatment antiepileptic drug medication may affect vitamin D metabolism ( e.g. , phenobarbital , phenytoin , rifampicin ) . 6 . History hypervitaminosis D 7 . Completion course high dose vitamin D within precede 2 month .</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>